Search

Search Constraints

You searched for: Author/Creator Fukuhara, Suguru

Search Results

1. A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma. Issue 3 (4th December 2019)

2. A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia. (27th November 2020)

3. A retrospective analysis of combination chemotherapy consisting cyclophosphamide, vincristine, prednisolone and procarbazine (C-MOPP) for pretreated aggressive non-Hodgkin lymphoma. (3rd March 2016)

4. Acute megakaryoblastic leukaemia with t(1;22)(p13·3;q13·1)/RBM15‐MKL1 in an adult patient following a non‐mediastinal germ cell tumour. (23rd June 2020)

5. Azacitidine-induced acute lung injury in a patient with therapy-related myelodysplastic syndrome. (April 2017)

6. CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib. Issue 6 (1st May 2021)

7. Clinicopathological analysis of primary refractory diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy. (9th June 2021)

8. Clinicopathological characteristics of follicular lymphoma with peripheral blood involvement. Issue 7 (July 2015)

9. Clinicopathological factors and tumor microenvironment markers predicting watch‐and‐wait discontinuation in 82 patients with follicular lymphoma. (5th May 2021)

10. Clinicopathological features of histological transformation from extranodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue to diffuse large B‐cell lymphoma: an analysis of 467 patients. (27th July 2016)